This information is intended for US healthcare professionals to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended for promotional purposes, nor to provide medical advice.

AKEEGA® (niraparib and abiraterone acetate)

Medical Information

Use of AKEEGA in Non-Metastatic Prostate Cancer

Last Updated: 06/27/2024

SUMMARY  

  • The efficacy and safety of the use of AKEEGA in non-metastatic prostate cancer has not been established.

Clinical Data

No clinical studies have been identified evaluating the use of AKEEGA for the treatment of patients with non-metastatic prostate cancer.

literature search

A literature search of MEDLINE®, Embase®, BIOSIS Previews®, and Derwent Drug File (and/or other resources, including internal/external databases) conducted on 27 June 2024 did not identify any relevant citations pertaining to this topic.